CSTA and ovarian cancer: Based on the data presented here, the combination of untargeted (MALDI-TOF MS protein profiling) and targeted (FLOWER) detection methods provides a powerful platform that has led to the detection of cystatin A, a promising candidate ovarian cancer biomarker.